Tana, Claudio https://orcid.org/0000-0002-9162-7866
Garcia-Azorin, David https://orcid.org/0000-0002-3132-1064
Raffaelli, Bianca https://orcid.org/0000-0001-9758-1494
Fitzek, Mira Pauline https://orcid.org/0000-0003-0299-4830
Waliszewska-Prosół, Marta https://orcid.org/0000-0002-9074-2803
Quintas, Sonia https://orcid.org/0000-0003-0622-8228
Martelletti, Paolo https://orcid.org/0000-0002-6556-4128
Article History
Received: 20 February 2025
Accepted: 10 April 2025
First Online: 8 May 2025
Declarations
:
: Claudio Tana is member of Editorial Board: The Journal of Headache and Pain and Editor of the Primary Care Section of Annals of Medicine. David Garcia Azorin is member of Editorial Board: The Journal of Headache and Pain, and has received research funding from the Regional Health Administration (Gerencia Regional de Salud SACYL) in Castilla y Leon, Spain. Speaker/travel grants/ clinical trials from Teva, Abbvie, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Biohaven. Bianca Raffaelli is member of Editorial Board: The Journal of Headache and Pain; reports personal fees from AbbVie, Eli Lilly, Lundbeck, Novartis, Organon, Perfood and Teva for participating in advisory boards and/or speaker activities as well as research funding from Lundbeck, Novartis, Else Kröner-Fresenius-Stiftung, German Research Foundation and German Migraine and Headache Society. Mira Pauline Fitzek reports personal fees from Teva, Novartis. Marta Waliszewska-Prosół is member of Editorial Board: The Journal of Headache and Pain; reports personal fees from AbbVie, Pfizer, Polpharma and Teva for speaker activities. Sonia Quintas has received honoraria from Lilly, Novartis, Exeltis, UCB Pharma, Bial and Altermedica. Paolo Martelletti is the Editor-in-Chief of The Journal of Headache and Pain and of SN Comprehensive Clinical Medicine.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.